Navigation Links
ev3 Inc. Appoints Douglas W. Kohrs to Board of Directors
Date:8/4/2008

PLYMOUTH, Minn., Aug. 4 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV), a global endovascular device company, today announced the appointment of Douglas W. Kohrs to its Board of Directors effective immediately. Mr. Kohrs will also serve as a member of the Compensation Committee. Mr. Kohrs previously served as a director of ev3 from June 2005 until October 2007 at which time Mr. Kohrs voluntarily resigned in order to facilitate the completion of ev3's acquisition of FoxHollow Technologies, Inc.

Mr. Kohrs is the President and Chief Executive Officer of Tornier B.V., a privately held global orthopedic company. Prior to joining Tornier B.V., Mr. Kohrs served as Chief Executive Officer of American Medical Systems Holdings, Inc. from April 1999 until January 2005. He served on the board of directors of American Medical Systems Holdings from 1999 to May 2006, and served as chairman of the board from March 2004 to May 2006. Mr. Kohrs is a member of the board of directors Tornier B.V. and The Institute for Health Technology Studies (InHealth), a not-for-profit medical device research organization.

About ev3 Inc.

Since its founding in 2000, ev3 has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of lower extremity vascular and neurovascular diseases. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net.

ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.


'/>"/>
SOURCE ev3 Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WellPoint Appoints Krista A. Bowers as President of Senior Business
2. WuXi PharmaTech (NYSE: WX) Appoints Mr. Steven M. Hutchins as VP of Business Development
3. VASAMED(R) Appoints Craig M. Walker, MD to Board of Directors
4. Colombia Appoints Dallas Chiropractor to Olympic Team
5. SyntheMed Appoints Corinne Mundin as Director, International Market Development
6. IDC appoints new Vice President for Latin America
7. HealthSouth Appoints Mary Ann Arico as SVP - Investor Relations and Corporate Communications
8. Althea Technologies Appoints E.J. Brandreth to Vice President of Quality and Regulatory
9. American Hospital Management Company Appoints Gregory Ciottone, MD as Chief Medical Officer
10. American Laser Centers Appoints New Corporate Medical Director
11. SCAN Health Plan Appoints Arthur Henkel Vice President of Mergers and Acquisitions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... The ... supply chain professionals, will hold their first Northeast Regional AHVAP Meeting. For 2017, ... , “Increasingly, supply chain and value analysis professionals have a ‘seat at the ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... Conventional sodium testing methods are complicated and require expert user knowledge. In a ... analytical method dedicated to the simplified, yet highly accurate, determination of sodium. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... From 1999 ... alone responsible for over 33,000 of the 52,404 drug-related deaths in 2015.(2) To ... 1512, which proposes a tax on prescription opioids to fund drug rehabilitation and ...
(Date:3/25/2017)... ... 25, 2017 , ... Getting earned media coverage meaningful for Garden Media Group's ... through the year, Garden Media aims to provide material helpful to clients’ goals and ... pitching client’s key messages to gain coveted media placements, Garden Media wows clients ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mediaplanet today announces distribution of ... current obstacles facing infection prevention and offer strategies for the health care community ... , The print component of “Fighting Infection” is distributed within the Friday, ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... BOSTON , March 27, 2017 ... pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), ... commercialization of innovative therapies based upon tetracycline chemistry, ... sarecycline for the treatment of moderate to severe ... Sarecycline is a once-daily, oral, narrow spectrum tetracycline-derived ...
(Date:3/27/2017)... 2017  Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that ... Bisaro as Impax,s President and Chief Executive Officer ... 27, 2017. Mr. Bisaro will succeed J. Kevin ... Chief Executive Officer since December of 2016. ... experience, Mr. Bisaro, 56, is an accomplished global business ...
(Date:3/27/2017)... March 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), ... inherited liver diseases in children, today reported financial ... ended December 31, 2016 and provided an update ... continued to make progress during the fourth quarter ... from our non-human primate safety study, and with our ...
Breaking Medicine Technology: